– Selected by a Distinguished Jury of Global Biopharma Leaders for Dren Bio’s Outstanding Innovation, Impact, and Scientific Excellence – SAN CARLOS, Calif.–(BUSINESS WIRE)–Dren Bio, a privately held, clinical-stage biotechnology company developing therapeutics for cancer, autoimmune, and other serious diseases, announced today that it received the 2025 Prix Galien USA Award for “Best Startup” by … [Read more…]
New endeavor focuses on a positive patient and caregiver experience from start to finish Co-founders bring more than 15 years of combined experience participating in clinical trials and know the importance of on-demand, high-touch support DURHAM, N.C.–(BUSINESS WIRE)–#biotech—Canary Advisors, an industry leader in patient engagement, today announced the launch of Canary Concierge, a personalized clinical … [Read more…]
Reports Revenue of $2.4 Billion, Growing 1%, and Net Income of $721 Million, or $1.63 per Diluted Share, Increasing 6% and 9%, Respectively, on a Reported Basis for Third Quarter 2025 Delivers 4% Organic Operational Growth in Revenue and 9% Organic Operational Growth in Adjusted Net Income for Third Quarter 2025 Reports Adjusted Net Income … [Read more…]
Company unveils patented technology designed to help maintain healthy blood flow during vascular procedures Backed by Sofinnova MD Start and led by experienced medtech entrepreneurs and cardiologists PARIS–(BUSINESS WIRE)–Tulyp Medical, a Paris-based startup developing a medical device for intelligent pressure-driven perfusion, emerged from stealth and announced it has submitted its 510(k) application to the U.S. … [Read more…]
GENEVA–(BUSINESS WIRE)–Alcon (SIX/NYSE: ALC), the global leader in eye care, today announced that it has filed an investor presentation in support of the proposed acquisition of STAAR Surgical Company (NASDAQ: STAA) with the U.S. Securities and Exchange Commission (SEC). Alcon plans to initiate outreach to STAAR stockholders and the presentation highlights key considerations for these … [Read more…]
DALLAS–(BUSINESS WIRE)–Tenet Healthcare Corporation (NYSE: THC) today announced the pricing of the previously announced private placement offering and has agreed to issue and sell $1.5 billion in aggregate principal amount of senior secured first lien notes due on November 15, 2032, which will bear interest at a rate of 5.500% per annum (the “first lien … [Read more…]
Milestone highlights a decade of academic excellence and commitment to nursing education PHOENIX–(BUSINESS WIRE)–University of Phoenix is proud to announce that its College of Nursing has achieved a significant milestone: ten consecutive years of accreditation for its Master of Science in Nursing (MSN) program by the Commission on Collegiate Nursing Education (CCNE). This achievement reflects … [Read more…]
Donor support accelerates academic research and clinical innovation NEW HYDE PARK, N.Y.–(BUSINESS WIRE)–Northwell Health announced recipients of nine endowments, including several inaugural chairs and professorships in specialty areas including biomedical sciences, nursing, geriatrics and palliative care, psychiatry research and cardiovascular and thoracic surgery. The new appointments were honored at the seventh annual Celebration of Excellence, … [Read more…]
Renowned Healthcare Experts and Executive Leaders to Direct Hospital Restructuring Charles R. Evans Named Chair of the Board; John Quinlivan Named CEO MONTGOMERY, Ala.–(BUSINESS WIRE)–Jackson Hospital today announced the appointment of a new three-member Board of Trustees and the selection of John Quinlivan as chief executive officer, marking a pivotal step forward in the hospital’s … [Read more…]
Findings Reinforce QDENGA’s Long-Term Safety Profile and Two-Dose Vaccination Schedule QDENGA is the Longest-Studied Dengue Vaccine and the Only Approved for Use Regardless of Prior Disease Exposure Takeda is Expanding Global Access to QDENGA in Partnership with National Immunization Programs, Private Payors and Public Health Coalitions, with 18.6 Million Doses Distributed in 11 Endemic Countries … [Read more…]
